Literature DB >> 29443232

Peripheral nervous system hyperexcitability in VV2 sporadic Creutzfeldt-Jakob disease.

Charlene J Ong1, Muhammad Al-Lozi1, Patrick J Cimino1, Robert Bucelli1.   

Abstract

Creutzfeldt-Jakob disease (CJD) is a fatal, rapidly progressive neurodegenerative disease. Most cases are sporadic (sCJD). The pathogenesis of sCJD is associated with a conformational change in abnormal prion protein causing widespread neuronal degeneration, and clinical manifestations can be quite protean. Peripheral nerve hyperexcitability syndrome (PNHS) is rarely associated with CJD and is more commonly associated with autoimmune/paraneoplastic syndromes associated with antibodies against the voltage-gated potassium channel complex (VGKC-Abs). Reports of PNHS in CJD are rare. We report 2 patients with progressive cognitive decline in the setting of peripheral nerve hyperexcitability on electrodiagnostic testing. In both patients VGKC-Abs were negative, and autopsy confirmed that both had sCJD, VV2 subtype. While uncommon, it is important to consider sCJD in patients presenting with PNHS and rapidly progressive dementia.

Entities:  

Year:  2015        PMID: 29443232      PMCID: PMC5764474          DOI: 10.1212/CPJ.0000000000000160

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  20 in total

1.  Demyelinating peripheral neuropathy in Creutzfeldt-Jakob disease.

Authors:  M Y Neufeld; J Josiphov; A D Korczyn
Journal:  Muscle Nerve       Date:  1992-11       Impact factor: 3.217

2.  Repetitive nerve stimulation for the evaluation of peripheral nerve hyperexcitability.

Authors:  Michael Benatar; Kristine M Chapman; Seward B Rutkove
Journal:  J Neurol Sci       Date:  2004-06-15       Impact factor: 3.181

Review 3.  Autoantibodies associated with diseases of the CNS: new developments and future challenges.

Authors:  Angela Vincent; Christian G Bien; Sarosh R Irani; Patrick Waters
Journal:  Lancet Neurol       Date:  2011-08       Impact factor: 44.182

4.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

5.  Phenotypic variants of autoimmune peripheral nerve hyperexcitability.

Authors:  Ian K Hart; Paul Maddison; John Newsom-Davis; Angela Vincent; Kerry R Mills
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

6.  Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene.

Authors:  J C Antoine; J L Laplanche; J F Mosnier; P Beaudry; J Chatelain; D Michel
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

7.  Autoantibodies in sporadic Creutzfeldt-Jakob disease.

Authors:  Heather Angus-Leppan; Peter Rudge; Simon Mead; John Collinge; Angela Vincent
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

8.  Diagnosis and treatment of rapidly progressive dementias.

Authors:  Ross W Paterson; Leonel T Takada; Michael D Geschwind
Journal:  Neurol Clin Pract       Date:  2012-09

Review 9.  Sporadic and familial CJD: classification and characterisation.

Authors:  Pierluigi Gambetti; Qingzhong Kong; Wenquan Zou; Piero Parchi; Shu G Chen
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

10.  A novel prion disease associated with diarrhea and autonomic neuropathy.

Authors:  Simon Mead; Sonia Gandhi; Janice L Holton; John Collinge; Jon Beck; Diana Caine; Dillip Gallujipali; Christopher Carswell; Harpreet Hyare; Susan Joiner; Hilary Ayling; Tammaryn Lashley; Jacqueline M Linehan; Huda Al-Doujaily; Bernadette Sharps; Tamas Revesz; Malin K Sandberg; Mary M Reilly; Martin Koltzenburg; Alastair Forbes; Peter Rudge; Sebastian Brandner; Jason D Warren; Jonathan D F Wadsworth; Nicholas W Wood
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.